Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Dexlansoprazole 60 mg Delayed Release Capsules and Esomeprazole 40 mg Delayed Release Capsules on Bone Homeostasis in Healthy Postmenopausal Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Dexlansoprazole (Primary) ; Esomeprazole
- Indications Bleeding ulcer; Erosive oesophagitis; Gastro-oesophageal reflux; Helicobacter infections; NSAID-induced ulcer; Peptic ulcer; Zollinger-Ellison syndrome
- Focus Biomarker; Pharmacodynamics
- Sponsors Takeda
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week
- 02 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 18 Feb 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.